Contact VaxLiant:


A new generation of advancing vaccines

Rooted in sound science, our novel adjuvants are backed by research and an experienced development team.

Ready-to-use ENABL adjuvants and fully customizable BioMize antigen-delivery systems enable:

  • in vitro screening
  • Similar efficacy using less antigen
  • Ability to recover antigen for product-release assays
  • Stimulation of different immune responses
  • Different formulations (e.g., DNA, gene vector, subunit, modified-live virus, killed virus)
  • Different routes of inoculation
  • Protection with a single dose
  • A stronger immune response
  • Ability to meet product-approval safety and withdrawal requirements
  • Long-lasting stability

To view some of our research, select a "species" or "adjuvant benefit" from these pull-down menus: